Tag Archives: dementia
Study identifies new culprit in Alzheimer’s disease development
LOS ANGELES: A recent study conducted at Nathan S. Kline Institute for Psychiatric Research (NKI) and NYU Langone Medical Center implicates a new culprit in Alzheimer’s disease development. The research reveals that ßCTF – the precursor of the amyloid beta (Aß) peptide – acts at the Read More »
New Alzheimer’s disease drug could slow decline in dementia patients
LAS VEGAS: Dementia experts are cautiously optimistic a new drug could slow the progression of dementia by one-third.
New findings into a drug called solanezumab have been released.
Neurologist Dr Eric Siemers — who works with the drug’s manufacturer Eli Lilly — said the medication Read More »
Experimental therapy prevents long-term brain damage in severely injured mice
SAN JOSE: Traumatic brain injury leads to the disruption of scaffolding structures in the neurons.
An experimental treatment helps restore normal brain structure and function in mice that have sustained severe concussions, and could lead to a drug that would do the same in humans, Read More »
Alzheimer’s biotech vTv Therapeutics sets terms for IPO
LOS ANGELES: vTv Therapeutics, a biotech developing treatments for Alzheimer’s disease and type 2 diabetes, announced terms for its IPO on Monday.
The High Point, NC-based company plans to raise capital by offering 7.8 million shares.
vTv Therapeutics was founded in 1999. It initially filed confidentially Read More »